IRWD
Ironwood Pharmaceuticals, Inc.
NASDAQ · Healthcare · Drug Manufacturers - Specialty & Generic · US
$4.26
−0.70%Margins
Gross margin
99.8%
EBITDA margin
62.0%
EBIT margin
60.6%
Net margin
33.4%
FCF margin
47.7%
-80.2%
Return on equity
45.5%
Return on assets
100.4%
Return on invested capital
1.08x
Asset turnover
$185.6M
Cash from operations
$0.48
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Jun 1, 2026